宠物液态生物检体市场规模、份额和增长分析：按产品、循环生物标记、技术、应用、最终用途和地区划分 - 2026-2033 年行业预测

2024年全球宠物液态生物检体市场价值为2.456亿美元，预计将从2025年的2.8367亿美元成长到2033年的8.9839亿美元。预测期（2026-2033年）的复合年增长率预计为15.5%。

全球宠物液态生物检体市场分析显示，受宠物饲养量增加和兽医保健支出成长的推动，对非侵入性癌症诊断的需求日益增长。该市场主要由检测肿瘤细胞游离DNA的血液检测主导，从而实现对伴侣动物的早期发现、分期和后续观察。随着饲主寻求与家人相同的先进治疗方案，对创新诊断技术的需求也日益迫切。这个领域源自于人类肿瘤学，越来越多的公司正在开发适用于犬猫的检测方法。专业诊所的早期应用已证实了这些技术的临床价值。此外，人工智慧技术透过将分子数据与细胞学数据相结合，增强了对低浓度肿瘤讯号的检测能力，并提高了诊断准确性。这简化了工作流程，促进了更广泛地应用，从而改善了患者照护。

全球宠物液态生物检体市场驱动因素

人们对宠物癌症风险的日益关注，以及饲主主人对非侵入性诊断方案的强烈偏好，显着提升了人们对液态生物检体的兴趣。兽医专业人士高度重视这项技术，因为它有助于早期发现癌症，并在无需手术干预的情况下辅助治疗决策。液态生物检体满足了这些需求，它提供了一种在最大限度减少动物压力的同时，实现定期监测和检体采集的方法。饲主的偏好与临床评估的契合，推动了液态生物检体服务的普及，扩大了市场潜力，并刺激了对相关技术创新和服务交付的投资。

全球宠物液态生物检体市场面临的限制因素

全球宠物液态生物检体市场面临许多限制因素，主要原因是高级兽医诊断的保险保障不足以及报销管道有限。这种情况导致宠物饲主自付费用增加，从而降低他们进行液态生物检体的意愿，最终影响兽医诊所的收入稳定性。缺乏完善的报销机制会给客户带来经济负担，也可能使兽医不愿推荐此类诊断测试。此外，对于小规模的兽医诊所而言，投资必要技术的不确定性可能会阻碍液态生物检体的常规应用，并影响市场的整体成长和永续性。

全球PET液态生物检体市场趋势

在全球宠物液态生物检体市场，居家检测正成为一种显着趋势，这主要源自于饲主对便利性和微创性检测的需求。製造商正致力于开发简化的检体采集设备和易于理解的操作指南，以提高检测依从性并加速疾病的早期发现。兽医医院和远端医疗服务提供者正将这些居家检测方案整合到其诊疗通讯协定中，以加强慢性疾病的管理，同时最大限度地减少宠物的压力。这一趋势不仅透过直接与宠物饲主互动扩大了市场进入，也支持了基于订阅的服务模式，透过定期检测和远端结果解读来建立持续的医病关係。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球宠物液态生物检体市场规模：按产品和复合年增长率划分（2026-2033 年）

• 消耗品
  • 试剂盒和试剂
  • 检测和检测组
• 装置
• 软体和服务

全球宠物液态生物检体市场规模：按循环生物标记和复合年增长率划分（2026-2033 年）

• 循环性肿瘤细胞
• 循环肿瘤DNA
• 细胞中的游离DNA
• 细胞外囊泡
• 其他生物标誌物

全球宠物液态生物检体市场规模：按技术和复合年增长率划分（2026-2033 年）

• 多基因平行分析
• 单基因分析

全球宠物液态生物检体市场规模：按应用及复合年增长率划分（2026-2033 年）

• 治疗监测
• 预后和復发监测
• 治疗方案
• 诊断和筛检

全球宠物液态生物检体市场规模：按最终用途和复合年增长率划分（2026-2033 年）

• 动物医院
• 宠物诊所
• 其他最终用户

全球宠物液态生物检体市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Fidoforce
• Vidium Animal Health
• Illumina
• Thermo Fisher Scientific
• Heska Corporation
• PetDx
• QIAGEN
• Volition
• Freenome Holdings
• Vethos
• Embark Veterinary
• One Health
• Ellie Diagnostics
• TGen
• MiDOG
• Basepaws
• Antech Diagnostics
• Pet-X
• AnimalBiome
• Exact Sciences Corporation

结论与建议

Global Pet Liquid Biopsy Market size was valued at USD 245.6 Million in 2024 and is poised to grow from USD 283.67 Million in 2025 to USD 898.39 Million by 2033, growing at a CAGR of 15.5% during the forecast period (2026-2033).

Market insights into the Global Pet Liquid Biopsy sector reveal an increasing demand for noninvasive cancer diagnostics, driven by the rise in pet ownership and veterinary expenditures. This market features blood-based assays that detect tumor-derived cell-free DNA, allowing for early detection, staging, and treatment monitoring of companion animals. As pet owners seek advanced treatment options akin to family care, the need for innovative diagnostics intensifies. The evolution of this field from human oncology has led to companies developing canine and feline assays, with early adopters in specialty clinics showcasing their clinical value. Furthermore, AI technologies enhance diagnostic accuracy by improving detection of low-abundance tumor signals and linking molecular data with cytology, streamlining workflows and stimulating broader adoption for enhanced patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pet Liquid Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pet Liquid Biopsy Market Segments Analysis

Global pet liquid biopsy market is segmented by product, circulating biomarkers, technology, application, end use and region. Based on product, the market is segmented into Consumables, Instruments and Software and Services. Based on circulating biomarkers, the market is segmented into Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA, Extracellular Vesicles and Other Biomarkers. Based on technology, the market is segmented into Multi-Gene Parallel Analysis and Single Gene Analysis. Based on application, the market is segmented into Treatment Monitoring, Prognosis and Recurrence Monitoring, Treatment Selection and Diagnosis and Screening. Based on end use, the market is segmented into Veterinary Hospitals, Pet Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pet Liquid Biopsy Market

The growing recognition of cancer risks in pets, coupled with a strong inclination among pet owners for less invasive diagnostic solutions, has significantly heightened interest in liquid biopsy testing. Veterinary professionals appreciate techniques that facilitate earlier detection and enhance treatment decision-making without the need for surgical interventions. Liquid biopsies fulfill these requirements by offering a means for routine monitoring and sample collection with minimal stress for the animals. This alignment of owner preferences with clinical endorsement paves the way for increased adoption of liquid biopsy services, expanding market potential and spurring investments in associated innovations and offerings.

Restraints in the Global Pet Liquid Biopsy Market

The Global Pet Liquid Biopsy market faces significant constraints due to inadequate insurance coverage and limited reimbursement options for advanced veterinary diagnostics. This situation leads to heightened out-of-pocket expenses for pet owners, deterring them from pursuing liquid biopsy tests and thereby affecting the revenue stability of veterinary clinics. The lack of established reimbursement frameworks can make veterinarians hesitant to recommend these diagnostic tests, as they may impose a financial strain on clients. Additionally, smaller veterinary practices may experience uncertainty about investing in the necessary technologies, hindering the routine use of liquid biopsies and obstructing the overall growth and sustainability of the market.

Market Trends of the Global Pet Liquid Biopsy Market

The Global Pet Liquid Biopsy market is witnessing a significant shift towards at-home testing, fueled by pet owners' desire for convenient and minimally invasive diagnostic options. Manufacturers are innovating simplified collection devices and straightforward instructions to facilitate compliance and promote early disease detection. Veterinary clinics and telemedicine providers are incorporating these home testing solutions into their care protocols, thereby enhancing chronic disease management while minimizing stress for pets. This trend not only expands market access by directly engaging pet owners but also supports subscription-based service models, fostering ongoing relationships through recurring testing and remote interpretation of results.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pet Liquid Biopsy Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Kits and Reagents
  • Assays and Panels
• Instruments
• Software and Services

Global Pet Liquid Biopsy Market Size by Circulating Biomarkers & CAGR (2026-2033)

• Market Overview
• Circulating Tumor Cells
• Circulating Tumor DNA
• Cell-Free DNA
• Extracellular Vesicles
• Other Biomarkers

Global Pet Liquid Biopsy Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Multi-Gene Parallel Analysis
• Single Gene Analysis

Global Pet Liquid Biopsy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Treatment Monitoring
• Prognosis and Recurrence Monitoring
• Treatment Selection
• Diagnosis and Screening

Global Pet Liquid Biopsy Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Pet Clinics
• Other End Users

Global Pet Liquid Biopsy Market Size & CAGR (2026-2033)

• North America (Product, Circulating Biomarkers, Technology, Application, End Use)
  • US
  • Canada
• Europe (Product, Circulating Biomarkers, Technology, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Circulating Biomarkers, Technology, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Circulating Biomarkers, Technology, Application, End Use)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Circulating Biomarkers, Technology, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Fidoforce
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vidium Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Freenome Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vethos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Embark Veterinary
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• One Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ellie Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiDOG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Basepaws
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antech Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pet-X
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AnimalBiome
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations